Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst

Barclays analyst Matt Miksic initiated coverage on Anteris Technologies Global Corp. AVR with a Positive rating and a forecast of $22.

The analyst notes that Anteris Technologies’ DurAVR valve system is expected to become the second balloon-expandable transcatheter valve replacement (BEV TAVR) system by 2028

Clinicians show a clear preference for BEV TAVR systems over self-expanding (SEV) systems from Medtronic plc. MDT and Abbott Laboratories ABT.

The analyst points out that DurAVR, positioned as an emerging next-gen TAVR player, is on track to capture 4%-5% of the U.S. TAVR market by 2030.

Despite strong data from MDT in 2024, clinicians still favor balloon-expandable (BEV) TAVR systems, of which DurAVR is set to be the second.

Also Read: Meta Drops Fact-Checking For Community Notes: Zuckerberg Sees ‘Opportunity To Restore Free Expression’

The analyst estimates that in the U.S., around 130,000 isolated aortic valve replacement (AVR) procedures are performed annually, out of about 550,000 patients with symptomatic severe aortic stenosis (ssAS). Additionally, 175,000 new ssAS patients are diagnosed each year, while 100,000 patients die annually due to lack of treatment.

Although TAVR market growth has slowed, the analyst sees the market as underpenetrated and views it as a promising target for the next-gen DurAVR platform.

In addition to its BEV delivery system, DurAVR offers superior hemodynamics and laminar blood flow, combining the best features of leading TAVR platforms for more favorable hemodynamics and a low-profile valve height.

Early clinical evidence suggests that DurAVR could outperform other leading TAVR platforms in areas such as hemodynamics, outcomes in valve-in-valve (VIV) procedures and potentially in long-term durability, thanks to the company’s proprietary ADAPT tissue technology, Miksic writes.

For FY25, the analyst estimates the company to report a loss of $(1.30) per share.

Price Action: AVR shares are trading higher by 2.67% to $5.760 at last check Tuesday.

Read now:

• AMD Unveils ‘Next Generation' AI Processors, Gaming Gear Ahead Of CES 2025

Anteris logo courtesy of company